Author(s)
Martelletti P1, Quintana R2, Carboni V3, Schwedt TJ4, Lanteri-Minet M5, Diener H6, Laflamme A7, Ruiz de la Torre E8, Craven A9, Evans S10, Walsh D11, Rasmussen AV12, Dumas P13, Fink R7, Fiorin A7, Ribbe S7, Vo P7
1EHF, Rome, Italy, 2GfK, Madrid, Spain, 3GfK Health, Basel, Switzerland, 4Mayo Clinic, Phoenix, AZ, USA, 5Centre Hospitalo-Universitaire de Nice, Nice, France, 6University Duisburg, Essen, Germany, 7Novartis Pharma AG, Basel, Switzerland, 8Head Global Patient Advocacy NS, Brussels, Belgium, 9Migraine Association of Ireland, Dublin, Ireland, 10Migraine Action UK, Leicester, UK, 11European Federation of Neurological Associations, Brussels, Belgium, 12Rigshospitalet, Glostrup, Denmark, 13Migraine Again LLC, Alabama, AL, USA
OBJECTIVES: This study aimed to evaluate the real-world healthcare resource utilization due to migraine, particularly among individuals who suffer from at least 4 monthly migraine days (MMDs) and may be eligible for, or receiving prophylactic treatment. METHODS: A cross-sectional study was conducted using an online survey of migraine patients across 31 countries (Africa, America, Asia and Europe), recruited via online panels and patient organizations. Study participants were adults (>=18 years) who reported having >=4 MMDs over the 3 months preceding the time of the survey (September 2017-February 2018), with pre-specified 90% among those having reported having used preventive migraine treatment. RESULTS: A total of 11,266 migraine patients responded to the survey (75% women, mean age: 39 years old). Migraine patients with at least 4 MMDs reported visiting different healthcare professionals (HCP) in a 6-month period due to their migraine. In the previous 12 months, 38% of patients visited the Emergency room (ER) an average 3.3 times, and 23% stayed in hospital overnight for an average of 3.2 days. Brain scans were performed on 58% of patients on average 2.1 times. These proportions were both higher in Turkey, India, Brazil, Indonesia, Poland, USA, Portugal, Russia, and also for migraine patients who have failed >=2 prophylactic treatments. CONCLUSIONS: Migraine patients (>= 4MMD) reported a high rate of HCP, ER visits and overnight stays in the hospital due to migraine; results indicate that the burden is higher among those who have failed a prophylactic migraine treatment and this trend increased with the number of prophylactic treatment failures.
Conference/Value in Health Info
2018-11, ISPOR Europe 2018, Barcelona, Spain
Value in Health, Vol. 21, S3 (October 2018)
Code
PND82
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Neurological Disorders